Monthly Archives: January 2012

A Process Platform, Not A Process Tool

Posted on January 31, 2012 by

It’s true that ’platform’ sounds like Marketing-speak.  But there’s an important distinction between a process tool and a process platform.  And it’s not widely appreciated, which is why so many organizations continue to waste so many millions of dollars on process tools that can never … Continue reading →

Posted in Integrated Compliance, Process Excellence, Process Platform | Tagged , , , , , , , | 3 Comments

Selling Process Excellence

Posted on January 26, 2012 by

Great animation What Is Process Excellence? just published by the Process Excellence Network (PEX).  The story behind the video is interesting as well. It’s good because it de-mystifies process.  Too many people think that process is the domain of the IT crowd … Continue reading →

Posted in Next Gen Pharma, Process Excellence | Tagged , , , , , , | Leave a comment

Goodbye To The SOP As A 50 Page Word Document

Posted on January 24, 2012 by

Everything points to this as an inflection point (scientific napkin view - left). There’s an increasing number of people in Life Sciences looking for a better way of managing the knowledge that has traditionally been deposited in a vast library of SOP documents that are read, mostly, … Continue reading →

Posted in Next Gen Pharma, Process SOPs | Tagged , , , , | Leave a comment

The Power of Process Visualization

Posted on January 17, 2012 by

My colleague Craig Willis has an interesting post out today on the power of process visualization in enabling collaboration. In process discovery especially, a well-run workshop forces the process actors to let go lazy intuition and really understand what’s happening: The act of … Continue reading →

Posted in Cracking Complexity | Tagged , , | Leave a comment

Why Process Excellence Will Underpin Next Generation Pharma

Posted on January 6, 2012 by

Organizations across the planet are grappling with how to fundamentally re-invent themselves, and at an ever-increasing pace of change. But few industries face the challenges of Pharma, which may traditionally have been seen as conservative and slow-moving, but is set to undergo a rapid revolution … Continue reading →

Posted in Next Gen Pharma | Tagged , , , , | Leave a comment